2010
DOI: 10.1016/j.brainres.2010.09.011
|View full text |Cite
|
Sign up to set email alerts
|

Effects of tetramethylpyrazine on nitric oxide/cGMP signaling after cerebral vasospasm in rabbits

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
16
0

Year Published

2011
2011
2018
2018

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 28 publications
(16 citation statements)
references
References 38 publications
0
16
0
Order By: Relevance
“…External supplementation of NO was shown to prevent or reverse CV in many experimental studies. 28,29 A new generation of NO donors has been in the focus of recent research to avoid the drawbacks of classic drugs. Different NO donors have been tested with regard to their potential role in treating CV.…”
Section: Discussionmentioning
confidence: 99%
“…External supplementation of NO was shown to prevent or reverse CV in many experimental studies. 28,29 A new generation of NO donors has been in the focus of recent research to avoid the drawbacks of classic drugs. Different NO donors have been tested with regard to their potential role in treating CV.…”
Section: Discussionmentioning
confidence: 99%
“…It has been suggested that EBI may exacerbate, maintain and even trigger DCVS 12 , and as such this model may aid in investigating both the early and late DCVS phases, including EBI and DCVS interactions following SAH. In particular, repeatable in vivo DCVS monitoring techniques including DSA 13 , computed tomography angiography 14 , and transcranial Doppler 15 are more readibly applied in rabbits than in smaller laboratory animals. In addition to enabling examiner-independent spontaneous SAH, the model allows the user to control for different degrees of severity (amount of blood or ICP, and consequent changes in cerebral perfusion pressure).…”
Section: Discussionmentioning
confidence: 99%
“…Like the parental herb, TMP (also called ligustrazine) is widely used to treat vascular diseases in China, with few adverse reactions in humans [11]. TMP has a long history of use, and the latest studies report its antioxidant proficiency in animal models of ischemic reperfusion [12], atherosclerosis [13], and cerebral vasospasm [14]. However, the underlying mechanism of TMP to combat detrimental ROS production and to rescue endothelial dysfunction in artery walls remains unclear.…”
Section: Introductionmentioning
confidence: 99%